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Psychiatric  co-morbidities  in Crohn’s  disease: an  often
overlooked aspect
Comorbidades  psiquiátricas  na  doenc¸a  de  Crohn:  um  aspecto
geralmente  negligenciado
Dear Editor,
I  read with great interest the  recent article by Lima et al., 1
Crohn’s disease may  be associated with signiﬁcant psychiatric
illnesses.
An  incidence rate of depression as high as 32% has
been reported in patients with underlying Crohn’s disease.2
Higher degrees of depression are observed in patients with
a  poor quality of life. Younger individuals with underly-
ing  Crohn’s disease are almost 2.75 times more  likely to
develop  persistent depression.3 Similarly, patients with low
economic  status tend to develop a more  severe degree of
depression.4 Individuals with extra-intestinal involvement,
such as joint involvement, also tend to report higher degrees of
depression.
A  similar association is observed with the  devel-
opment of anxiety in Crohn’s disease patients. Nearly
24% of them develop anxiety.3 In a  recent study, Lof-
tus  et al. showed that younger patients with underly-
ing Crohn’s disease are almost 4.35 times more  likely
to  develop persistent anxiety. 3 Certain therapies, such
as  inﬂiximab, actually worsen the  anxiety. Crohn’s dis-
ease  patients also report high degrees of fatigue, which
may  be exacerbated by the development of concurrent
depression.5
Similarly, patients may  present with isolated bipolar
disorder.6 Treatment with steroids especially predisposes
Crohn’s disease patients to manic episodes. Holroyd et al., in a
recent study, reported that nearly 57% of patients with Crohn’s
disease  who developed a  manic episode had received recent
prednisone therapy.7
The above examples clearly highlight the signiﬁcant psy-
chiatric  co-morbidity of Crohn’s disease and the need to
address  these as soon as possible after the diagnosis is
made.
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